|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02367 GIANT BIOGENE
Nominal 
29.600 +1.160 (+4.079%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 2,917,692 | -6.264% | 3,112,662 | 2,540,432 | 1,605,698 | 984,891 |
| Cost of Sales | (599,284) | 5.079% | (570,317) | (447,192) | (254,702) | (146,637) |
| Gross Profit | 2,318,408 | -8.808% | 2,542,345 | 2,093,240 | 1,350,996 | 838,254 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (383) | -- | 119 | (490) | 332 | 147 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 9,828 | -- | (914) | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 1,094,955 | -24.180% | 1,444,148 | 1,155,190 | 775,583 | 513,093 | |
| Taxation | (155,427) | -40.610% | (261,704) | (174,640) | (109,560) | (75,850) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 186 | -- | (361) | 2,614 | 917 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 939,714 | -20.504% | 1,182,083 | 983,164 | 666,940 | 437,243 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (116,624) | 84.322% | (63,272) | (38,937) | (23,701) | (6,663) |
| Depreciation & Amortisation | 46,469 | 22.703% | 37,871 | 20,851 | 16,869 | 13,941 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 89.000 | -21.930% | 114.000 | 99.000 | 67.000 | 45.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 8.814 | -- | 8.569 | 5.806 | 3.528 | -- |
| Remarks: | Real time quote last updated: 20/08/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 939,714 |
| %Change | -20.504% |
| EPS / (LPS) | RMB 0.890 |
| NBV Per Share (¥) | RMB 8.814 |